Status of work in February
AOTMiT begins work on the Ministry of Health’s orders in February:
- Voydeya (danicopan) in the treatment of patients with paroxysmal nocturnal hemoglobinuria
- Uplizna (inebilizumab) in the treatment of patients with optic neuritis and spinal cord inflammation
The listed orders are available on the AOTMiT Public Information Bulletin.